Skip to content

Author

Ayane Seko

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Case report Open access Oct 2026

Immune Checkpoint Inhibitor-Related Bullous Pemphigoid with Negative Direct Immunofluorescence during Pembrolizumab Plus Lenvatinib Therapy: A Case Report

Abstract Introduction Bullous pemphigoid (BP) is a rare but clinically significant cutaneous immune-related adverse event (irAE) of immune checkpoint inhibitor (ICI) therapy. It is most often described during treatment of melanoma, lung cancer, and renal cell carcinoma, whereas reports in gynecologic oncology, and spec...

Ayane Seko, Shimpei Nagai, M. Hino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.